{
    "clinical_study": {
        "@rank": "30299", 
        "arm_group": [
            {
                "arm_group_label": "1", 
                "arm_group_type": "Experimental", 
                "description": "Maintenance treatment with daily medication"
            }, 
            {
                "arm_group_label": "2", 
                "arm_group_type": "Experimental", 
                "description": "Maintenance treatment with thrice-weekly medication"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to assess optimal dosage of buprenorphine on a thrice weekly\n      schedule in a pilot clinical trial."
        }, 
        "brief_title": "Buprenorphine Maintenance Dose Schedule and Treatment Setting - 1", 
        "completion_date": {
            "#text": "August 2007", 
            "@type": "Actual"
        }, 
        "condition": [
            "Opioid-Related Disorders", 
            "Substance-Related Disorders"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Opioid-Related Disorders", 
                "Substance-Related Disorders"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Please contact site for information."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "55 Years", 
            "minimum_age": "21 Years"
        }, 
        "enrollment": {
            "#text": "202", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "September 20, 1999", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00000318", 
            "org_study_id": "NIDA-09803-1", 
            "secondary_id": "R01-09803-1"
        }, 
        "intervention": {
            "arm_group_label": [
                "1", 
                "2"
            ], 
            "description": "Experimental Maintenance treatment with daily medication\nExperimental Maintenance treatment with thrice-weekly medication", 
            "intervention_name": "Buprenorphine", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": "Buprenorphine"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "December 17, 2008", 
        "location": {
            "facility": {
                "address": {
                    "city": "New Haven", 
                    "country": "United States", 
                    "state": "Connecticut", 
                    "zip": "06519"
                }, 
                "name": "APT Residential Services Division"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Buprenorphine Maintenance Dose Schedule and Treatment Setting: Pilot", 
        "overall_official": {
            "affiliation": "Yale University", 
            "last_name": "Richard Schottenfeld, M.D.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Federal Government", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "March 2004", 
            "@type": "Actual"
        }, 
        "primary_outcome": [
            {
                "measure": "Opioid and cocaine use", 
                "safety_issue": "No", 
                "time_frame": "26 weeks"
            }, 
            {
                "measure": "Social and psychological functioning", 
                "safety_issue": "No", 
                "time_frame": "26 weeks"
            }, 
            {
                "measure": "AIDS risk behavior", 
                "safety_issue": "No", 
                "time_frame": "26 weeks"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00000318"
        }, 
        "responsible_party": {
            "name_title": "Richard S. Schottenfeld, MD", 
            "organization": "Yale University School of Medicine"
        }, 
        "source": "National Institute on Drug Abuse (NIDA)", 
        "sponsors": {
            "collaborator": {
                "agency": "Yale University", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "National Institute on Drug Abuse (NIDA)", 
                "agency_class": "NIH"
            }
        }, 
        "start_date": "December 1994", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Factorial Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "December 2008"
    }, 
    "geocoordinates": {
        "APT Residential Services Division": "41.308 -72.928"
    }
}